Drug Type Cell therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebral Palsy | Phase 2 | JP | 11 Oct 2023 | |
Eye Diseases | Phase 2 | JP | 11 Oct 2023 | |
Nervous System Diseases | Phase 2 | JP | 11 Oct 2023 | |
Spinal Cord Injuries | Phase 2 | JP | 11 Oct 2023 | |
Cerebral Palsy | Preclinical | JP | 11 Oct 2023 | |
Cerebral Palsy | Preclinical | JP | 11 Oct 2023 | |
Eye Diseases | Preclinical | JP | 11 Oct 2023 | |
Fractures, Ununited | Preclinical | JP | 11 Oct 2023 | |
Nervous System Diseases | Preclinical | JP | 11 Oct 2023 | |
Spinal Cord Injuries | Preclinical | JP | 11 Oct 2023 |